Bain, S., Shaman, A. M., Bakris, G. L., Buse, J. B., Idorn, T., Mahaffey, K. W., . . . Perkovic, V. (2022). Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER. Circulation, 145(8), pp. 575-585. doi:10.1161/circulationaha.121.055459
Chicago Style CitationBain, Steve, et al. "Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide On Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER." Circulation 145, no. 8 (2022): 575-585.
MLA CitationBain, Steve, et al. "Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide On Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER." Circulation 145.8 (2022): 575-585.